Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women

@article{Tran2017MethadoneBA,
  title={Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women},
  author={Tran H. Tran and Brooke L. Griffin and Rebecca H Stone and Kathleen M. Vest and Timothy J. Todd},
  journal={Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year={2017},
  volume={37}
}
Pregnant women with opioid use disorder can be treated with methadone, buprenorphine, or naltrexone to reduce opioid use and improve retention to treatment. In this review, we compare the pregnancy outcomes of methadone, buprenorphine, and naltrexone in clinical trials and discuss the potential behavioral and developmental effects of these agents seen in offspring in animal studies. Important clinical considerations in the management of opioid use disorder in pregnant women and their infants… Expand
Naltrexone Treatment for Pregnant Women With Opioid Use Disorder Compared With Matched Buprenorphine Control Subjects.
TLDR
Maintaining women on NTX during pregnancy was associated with favorable outcomes and support the need for larger multicenter studies sufficiently powered to detect possible differences between the medications on long-term maternal and child safety and efficacy outcomes. Expand
The opioid epidemic and pregnancy: implications for anesthetic care
TLDR
The dramatic rise in OUD in pregnancy has had staggering socioeconomic consequences, carrying with it profound maternal and fetal health problems, and Medication-assisted treatment utilizing either methadone, or more commonly buprenorphine is considered the standard of care for OUD during pregnancy. Expand
Opioid Use in Pregnancy
TLDR
Maintenance therapy with methadone or buprenorphine remains the standard of care for pregnant women with OUD given its consistent superiority to placebo in terms of rates of illicit drug use and pregnancy outcomes. Expand
Efficacy and Safety of Buprenorphine Maintenance Therapy during Pregnancy: A Case Report
TLDR
A case can be built supporting the notion that the use of opioid maintenance treatment at the time of conception and during pregnancy is not likely to have negative effects on pregnant women or newborns. Expand
Anesthetic management of the parturient with opioid addiction
TLDR
This review article will provide evidence-based approaches when available and share the experience in managing labor analgesia and cesarean delivery anesthesia in pregnant women with an OUD, from admission to the labor and delivery unit until hospital discharge. Expand
Understanding ED Buprenorphine Initiation for Opioid Use Disorder: A Guide for Emergency Nurses.
TLDR
With expanded understanding of opioid use disorder, withdrawal, and available treatments, emergency nurses will be better prepared to deliver and support life-saving treatments for patients and families suffering from this disease. Expand
Benzodiazepine withdrawal in pregnant women with opioid use disorders: An observational study of current clinical practices at a tertiary obstetrical hospital.
TLDR
An observational study of pregnant women with comorbid opioid and sedative-hypnotic use disorders hospitalized for benzodiazepine withdrawal identified patterns of withdrawal management, including the type of withdrawal protocol utilized, the total dosage of benzodiazine used during that protocol, and patient variables associated with higher dosing. Expand
Medication-Assisted Treatment for Opioid-Use Disorder.
TLDR
Using data from available medical literature, existing knowledge is synthesized and a framework for how to determine the optimal approach for outpatient management of OUD with medication-assisted treatments is provided. Expand
Opioid use disorder in pregnancy
  • K. Harter
  • Medicine
  • The mental health clinician
  • 2019
TLDR
The following key aspects of opioid use disorder in pregnancy are explored through the progression of a pregnancy via a patient case: treatment options, treatment decisions, substance use screening, dosing modifications, and other aspects of peripartum care. Expand
Post-cesarean delivery pain. Management of the opioid-dependent patient before, during and after cesarean delivery.
  • R. Landau
  • Medicine
  • International journal of obstetric anesthesia
  • 2019
TLDR
The existing literature on post-cesarean pain management in the obstetric patient with an opioid-use disorder is summarized to provide clinicians with a stepwise approach for management before, as well as during and after, cesarean delivery of women who have been chronically using opioids during their pregnancy. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 79 REFERENCES
The Effects of Maternally Administered Methadone, Buprenorphine and Naltrexone on Offspring: Review of Human and Animal Data
TLDR
Clinical observations suggest that buprenorphine during pregnancy is similar to methadone on developmental measures but is potentially superior in reducing the incidence and prognosis of NAS, and animal studies using oral or injectable naltrexone have shown developmental changes following exposure during pregnancy and lactation, raising concerns about its use in humans. Expand
Methadone and Buprenorphine for Opioid Dependence During Pregnancy: A Retrospective Cohort Study
TLDR
Pregnancy outcomes with buprenorphine to treat opioid dependence during pregnancy in clinical practice are as good and often better than outcomes with methadone, consistent with efficacy data from randomized clinical trials. Expand
Neonatal abstinence syndrome after methadone or buprenorphine exposure.
TLDR
A comparison of the 131 neonates whose mothers were followed to the end of pregnancy according to treatment group showed that the former group required significantly less morphine, which is consistent with the use of buprenorphine as an acceptable treatment for opioid dependence in pregnant women. Expand
Buprenorphine and Naloxone Compared With Methadone Treatment in Pregnancy
TLDR
In a cohort of pregnant patients treated with either methadone or buprenorphine and naloxone in pregnancy, newborns exposed to maternal buPrenorphines and nAloxone had less frequent neonatal abstinence syndrome. Expand
Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.
TLDR
Results suggest that buprenorphine is not inferior to methadone on outcome measures assessing NAS and maternal and neonatal safety when administered starting in the second trimester of pregnancy. Expand
Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study.
TLDR
This preliminary study had limited power to detect differences but the trends observed suggest this kind of research is practicable and that further studies are warranted. Expand
Buprenorphine, methadone, and morphine treatment during pregnancy: behavioral effects on the offspring in rats
TLDR
It is suggested that buprenorphine and methadone maintenance therapy for pregnant women, like morphine, produced detrimental effects on cognitive function and social behaviors, whereas the offsprings of such women might have a lower risk of developing anxiety disorders. Expand
Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study
TLDR
Buprenorphine appears to be as safe as the currently approved substitute methadone considered to date as the reference treatment for pregnant opioid-dependent women. Expand
Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
TLDR
Data from this non-randomized comparison suggest that buprenorphine may offer advantages for treatment of opiate dependence during pregnancy. Expand
Methadone maintenance vs. implantable naltrexone treatment in the pregnant heroin user
  • G. Hulse, G. O'neil, D. Arnold-Reed
  • Medicine
  • International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
  • 2004
TLDR
This brief communication reports obstetric and neonatal outcomes of 17 pregnant women who were managed with NIT (16 who conceived while on implant treatment) compared with 90 women who are managed with MMT, compared with national norms in Australia. Expand
...
1
2
3
4
5
...